nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A review of the safety of generic drugs
|
Dighe, S.V |
|
1999 |
31 |
3S1 |
p. 23S-24S nvt p. |
artikel |
2 |
Cyclosporine: the case for expanding bioequivalence criteria to include measures of individual bioequivalence in relevant population subsets
|
Barr, W.H |
|
1999 |
31 |
3S1 |
p. 25S-30S nvt p. |
artikel |
3 |
Generic drugs: the Canadian perspective
|
McGilveray, I.J |
|
1999 |
31 |
3S1 |
p. 16S-18S nvt p. |
artikel |
4 |
Generic immunosuppressants: the European perspective
|
Christians, U |
|
1999 |
31 |
3S1 |
p. 19S-22S nvt p. |
artikel |
5 |
Generic immunosuppressant use in solid organ transplantation
|
Alloway, R.R |
|
1999 |
31 |
3S1 |
p. 2S-5S nvt p. |
artikel |
6 |
History and regulatory issues of generic drugs
|
Meyer, G.F |
|
1999 |
31 |
3S1 |
p. 10S-12S nvt p. |
artikel |
7 |
Introduction
|
Benet, Leslie Z |
|
1999 |
31 |
3S1 |
p. 1S- 1 p. |
artikel |
8 |
Pediatric oncology and AIDS: therapeutic lessons of relevance to generic drug use
|
Rodman, J |
|
1999 |
31 |
3S1 |
p. 13S-15S nvt p. |
artikel |
9 |
Pharmacoeconomics of immunosuppressive agents in renal transplant recipients
|
Bennett, W.M |
|
1999 |
31 |
3S1 |
p. 6S- 1 p. |
artikel |
10 |
The impact of generic drugs on the cost of transplantation medical care
|
Olyaei, A.J |
|
1999 |
31 |
3S1 |
p. 31S-34S nvt p. |
artikel |
11 |
Understanding bioequivalence testing
|
Benet, L.Z |
|
1999 |
31 |
3S1 |
p. 7S-9S nvt p. |
artikel |